IbisVision
IbisVision is a Glasgow, UK-based remote ophthalmic SaaS company offering IBISengage (clinician-led remote vision testing and online refraction) and IBISrecheck (self-guided prescription verification) to optometry practices, optical retailers, and telemedicine providers across the UK, US, and EU.
- Company typePrivate
- Founded2019
- HeadquartersNewhouse, United Kingdom
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What IbisVision does
IbisVision is a Glasgow, UK-based remote ophthalmic technology company that sells SaaS platforms enabling online eye exams, remote refraction, and virtual eye care consultations. Its product suite is built around two core offerings: IBISengage, a clinician-first platform that integrates optometrists and eyecare professionals into the remote patient workflow for live remote vision testing and online refraction, and IBISrecheck, a self-guided prescription verification tool that uses pre-recorded voice instructions to walk patients through confirming their prescription on a single device. The stack additionally supports remote triage, video consultations, online appointment scheduling, and remote patient and disease-progression monitoring, addressing practice inefficiency, missed appointments, and limited geographic reach for in-person eye care.
The company sells primarily to eye care practices, optometry clinics, optical retailers, and broader telemedicine providers, segmented vertically. Revenue is generated on a SaaS subscription model with quote-based (undisclosed) pricing; prospects can self-onboard through a 14-day free trial of IBISengage, while enterprise and mid-market accounts are converted via a sales-assisted 'Schedule a Demo' motion, supplemented by a 'Partner With Us' channel/reseller program. The IbisVision, IBISengage, and IBISrecheck marks are registered brand identities. Current geographies span the UK (headquarters at 14 Mitchell Lane, Glasgow) and the US (Newark, Delaware office plus a planned Fort Lauderdale, Florida regional office), with the EU listed as a planned expansion market.
As of the most recent disclosure, IbisVision had received FDA listing (March 2023) and closed a £4.5 million growth funding round led by Compiler VC (with Deepbridge Capital and Scottish Enterprise) in May 2023, with stated use of funds covering US and EU expansion, US office buildout, and workforce growth. More than 2,000 vision tests have been conducted across IBISengage and IBISrecheck. Leadership comprises CEO Mark Roger, Service Director Justin Birley, and Business Development Manager Melville Peter Berwick; total headcount is reported at 1–10 employees, and revenue has not been publicly disclosed.
IbisVision firmographics
Firmographics- Name
- IbisVision
- Legal name
- IbisVision Ltd
- Website
- https://ibisvision.co.uk
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- IbisVision is a Glasgow, UK-based remote ophthalmic SaaS company offering IBISengage (clinician-led remote vision testing and online refraction) and IBISrecheck (self-guided prescription verification) to optometry practices, optical retailers, and telemedicine providers across the UK, US, and EU.
- Ownership category
- akta.pro rank
IbisVision industry classification
Industry- Product category
- Teleoptometry Software
- NAICS
- Offices of Optometrists (62132), Offices of Optometrists (621320)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Ophthalmology & Vision Telemedicine Platforms (HLALAGAL)
- akta.pro secondary industry
- Optical Dispensing & Eyewear Devices (Frames, Lenses, Lens Edging/Finishing Equipment) (HLAHAJAD)
Keywords
Where IbisVision is headquartered
LocationHeadquarters
- HQ city
- Newhouse
- HQ country
- United Kingdom
- HQ region
- Europe
Offices3 records
Markets served
IbisVision business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- SaaS Platform Subscriptions: IbisVision operates on a SaaS subscription model, offering access to its IBISengage and IBISrecheck platforms. The platform is offered via a 14-day trial followed by paid subscription. Pricing is quote-based, suggesting tiered enterprise plans.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Pay-as-you-go | 14-Day Free Trial |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
IbisVision product offering
Product offeringCore offering
IbisVision develops and sells remote ophthalmic technology platforms that enable eye care practices to deliver online eye exams, online refraction, remote triage, video consultations, appointment scheduling, and remote patient monitoring. Its two core products are IBISengage, a clinician-first platform integrating eyecare professionals into the remote patient experience, and IBISrecheck, a self-guided prescription verification tool with voice instructions that lets patients verify their own prescription on a single device from any location.
Product overview
IbisVision is a remote ophthalmic technology company offering a platform-plus-products architecture consisting of two core products: IBISengage and IBISrecheck. IBISengage is a clinician-first digital platform that integrates eyecare professionals into the patient experience, enabling remote vision tests including online refraction. IBISrecheck is a complementary self-guided test that enables patients to independently verify their own prescriptions, featuring voice-guided instructions. Together, these products provide a comprehensive remote eye care solution supporting online eye exams, remote triage, video consultations, appointment scheduling, and remote patient monitoring.
Differentiator
Problem solved
Functional benefit
Products and services
- IBISengage A clinician-first digital platform that integrates eyecare professionals fully into the patient experience, providing a suite of remote vision tests including online refraction with reliable, proven, and tested technology. It enables remote triage, video consultations, appointment scheduling, and remote patient and disease progression monitoring for eye care practices, optometry clinics, optical retailers, and telemedicine providers.
- IBISrecheck A completely self-guided prescription verification test that empowers patients to verify their own prescription on one device, wherever they are. It provides detailed voice instructions to guide patients through tests with ease, ensuring complete and accurate results. It is positioned to drive sales and increase traffic for eye care practices and optical retailers by enabling patients to validate prescriptions digitally.
Quantifiable outcome
- 2000+ vision tests completed using IBISrecheck and IBISengage platforms
- +1 more outcomes
Companies that use IbisVision
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
IbisVision technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature6 records
IbisVision partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights6 records
IbisVision competitors and assessment
Company assessmentDirect peers
- 20/20NOW: US-based teleoptometry company that provides remote eye exams and online refraction for optical retailers. Direct head-to-head competitor to IbisVision's IBISengage in the US teleoptometry segment.
- Visibly (formerly Opternative): Online vision test provider offering self-guided refraction and prescription renewal. Direct competitor in the digital/at-home refraction space targeted by IBISrecheck.
- EyeQue: Provides at-home vision testing devices and smartphone-based refraction tools. Comparable as a direct-to-consumer and clinical remote refraction alternative to IbisVision's self-guided IBISrecheck product.
Broad incumbents
- Topcon Healthcare: Large ophthalmic device and software incumbent with a broad portfolio of refraction, imaging, and practice management solutions, plus a growing teleoptometry/cloud strategy. Competes with IbisVision in the eyecare practice software stack.
- Carl Zeiss Meditec: Global ophthalmic medical technology company offering diagnostic devices, IOLs, and digital workflow software for eye care practices. Represents an established bundled-software-and-hardware competitor to IbisVision's platform.
- Nidek: Japanese manufacturer of ophthalmic and optometric equipment, including refraction and diagnostic systems with associated practice software. Incumbent competitor in the same eyecare practice ecosystem IbisVision targets.
- Warby Parker: DTC eyewear retailer that has built in-house telehealth and prescription renewal tooling (Virtual Vision Test). Adjacent competitor with significant brand and customer base in the online eyecare space.
- Luneau Technology (Briot / Weco): European-based provider of optometry equipment, lens edging systems, and practice management software. Competes with IbisVision for the same European eyecare practice software and refraction workflow budget.
Emerging players
- Digital Diagnostics: AI-driven diagnostic company with FDA-authorised autonomous diagnostic systems, including for diabetic retinopathy. Comparable as an emerging specialty telehealth/diagnostic platform pursuing FDA-cleared clinical software in adjacent ophthalmic indications.
- Eyenuk: AI eyecare company with FDA-cleared screening tools (e.g., EyeArt for diabetic retinopathy). Comparable as an emerging ophthalmology AI/telehealth company building clinically validated, regulatory-cleared software for eyecare professionals.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
IbisVision social profiles
Digital presenceIbisVision financial estimates
Financial estimateRevenue estimate
Valuation estimate
IbisVision leadership team
Management profileNumber of profiles
Profiles3 records
IbisVision funding detail
Funding detailFunding overview
Funding rounds3 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IbisVision M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IbisVision
What does IbisVision do?
IbisVision develops and sells remote ophthalmic technology platforms that enable eye care practices to deliver online eye exams, online refraction, remote triage, video consultations, appointment scheduling, and remote patient monitoring. Its two core products are IBISengage, a clinician-first platform integrating eyecare professionals into the remote patient experience, and IBISrecheck, a self-guided prescription verification tool with voice instructions that lets patients verify their own prescription on a single device from any location.
Is IbisVision a public or private company?
IbisVision is a private company. It is classified as venture growth investor backed and is currently operating.
When was IbisVision founded?
IbisVision was founded in 2019. It employs 1 to 10 people.
Where is IbisVision based?
IbisVision is headquartered in Newhouse, United Kingdom, in the Europe region.
How does IbisVision make money?
One revenue line is on record: saaS Platform Subscriptions.
Who are IbisVision's main competitors?
Direct peers on record are 20/20NOW, Visibly (formerly Opternative) and EyeQue. Broad incumbents are Topcon Healthcare, Carl Zeiss Meditec, Nidek, Warby Parker and Luneau Technology (Briot / Weco). Emerging players are Digital Diagnostics and Eyenuk.
Does IbisVision have an API?
No public API is recorded for IbisVision.
What industry is IbisVision in?
IbisVision's product category is Teleoptometry Software. Its primary akta.pro industry code is HLALAGAL, Ophthalmology & Vision Telemedicine Platforms, with a secondary code of HLAHAJAD, Optical Dispensing & Eyewear Devices (Frames, Lenses, Lens Edging/Finishing Equipment). Its NAICS code is 62132 and its SIC code is 3841.